Seventeen-year-old varsity basketball player demonstrates mind over matter in battling life-altering setbacks.

Mia Cassella told Newsweek: "Cancer might take away things like my hair or my energy, but it couldn't take away my passion for lifting and working out." ...

The FDA has approved a new three-drug combination to treat certain types of an aggressive blood cancer called large B-cell lymphoma (LBCL).

The FDA has approved Adcetris (brentuximab vedotin) for use in combination with lenalidomide and rituximab to treat patients with relapsed/refractory LBCL after 2 or more lines of systemic therapy who ...

New York–based hematologist-oncologist and clinical researcher works to lower the barriers to enrolling in clinical trials.

Among older adults with classical Hodgkin lymphoma, frontline N-AVD has been found to be highly effective and well-tolerated.

Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...

1. Lewis DJ, Jerkeman M, Sorrell L, et al. Ibrutinib-rituximab is superior to rituximab-chemotherapy in previously untreated older mantle cell lymphoma patients: results from the international ...

Chemotherapy is a common treatment for cancer, but determining its effectiveness can be complex. There are key signs, tests, and factors to help you understand if chemotherapy is working and how ...

IL-13 is a growth factor for tumor cells in mycosis fungoides and Hodgkin lymphoma and is produced by tumor cells of breast implant associated anaplastic large cell lymphoma. TGF-beta is a negative ...

This is probably because these patients frequently require multiple and prolonged cycles of chemo. People treated for ovarian cancer (32%) and lymphoma (36%) had the lowest risk. Researchers said ...

This is probably because these patients frequently require multiple and prolonged cycles of chemo. People treated for ovarian cancer (32%) and lymphoma (36%) had the lowest risk. Researchers said ...